🇺🇸 FDA
Patent

US 10875860

Azaindenoisoquinoline compounds and uses thereof

granted A61KA61K45/06A61P

Quick answer

US patent 10875860 (Azaindenoisoquinoline compounds and uses thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K45/06, A61P, A61P35/00, A61P35/04